Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models
Share Article
Inventia Life Science, a leader in automated generation of complex 3D cell models, and PhenoVista Biosciences, a top provider of custom imaging-based phenotypic assay services, have entered into a partnership to deliver high-content cell-based assay services for drug discovery.
The vision for RASTRUM is to revolutionise the way we approach the drug discovery process by accelerating the evolution of drugs from the lab bench to the hospital bed - Dr. Julio Ribeiro, CEO of Inventia Life Science SYDNEY (PRWEB) July 14, 2021 Inventia Life Science and PhenoVista Biosciences have secured a strategic partnership to super-charge 3D cell biology research services with the installation of Inventia’s 3D Cell Culture Platform – RASTRUM™ – at PhenoVista’s California site. This